Juul Labs CEO Announces Company's Next Steps

Oct.09.2022
Juul Labs CEO Announces Company's Next Steps
Juul CEO announces cancellation of overseas expansion plans, debt refinancing, and potential bankruptcy as the company fights for survival.

Recently, the CEO of Juul Labs Inc., KC Crosthwaite, announced that the company is canceling its plans for international expansion. They have also undergone a refinancing process for some of their debts and are currently struggling to keep the business afloat.


The board of directors, leadership team, and I are continuing to evaluate all options to ensure that we take the necessary steps to help us fight for our mission - a battle that has been going on for many years," said CEO KC Crosthwaite in a statement.


In the ongoing dispute with the U.S. Food and Drug Administration (FDA) over whether its e-cigarettes can remain on the U.S. market, Juul has been preparing to file for bankruptcy protection. Crosthwaite stated that the company is still considering various restructuring plans, including bankruptcy, but has not made any decisions yet.


Crosthwaite announced that the company will be laying off some employees after cancelling its plans to expand outside of the United States. He also stated that Juul has successfully refinanced its debt to allow for more time to explore longer-term options.


We firmly believe that we have a future in which millions of adult smokers around the world will be able to use Juul products," said Crosthwaite. "To make this future a reality, we must continue to fight and make difficult decisions.


In 2018, Juul disrupted the tobacco market when its stylish flash-drive shaped vaporizer drove a surge in electronic cigarette use in the United States. Since then, Juul has faced lawsuits and regulatory crackdowns. The company has attempted to repair its image by appointing a new CEO in 2019 and voluntarily discontinuing the sale of fruit flavors in the US, as well as ceasing most of its marketing activities in the country.


Juul Labs CEO KC Crosthwaite has announced that the company will be laying off employees following a decision to withdraw plans for international expansion. Juul, which had approximately 3,000 employees in 2019, has already cut two-thirds of its workforce due to declining sales and increased losses. The company currently employs around 1,200 workers, including approximately 100 outside of the US, and the impact of the latest layoff decisions on their positions is unclear at this time.


The company Juul had previously planned to expand distribution in Canada, with their latest device JUUL2 launching earlier this year and being sold online and in around three dozen stores in Toronto. Juul also plans to re-establish employees in Italy and Switzerland, where their original e-cigarettes are currently sold through local distributors.


In 2020, due to a voluntary decision to reduce marketing efforts and cease sales of their sweet and fruity flavors in the United States, the company withdrew from most international markets as a result of declining revenue. In June, the FDA ordered Juul to remove their e-cigarettes from the U.S. market, stating insufficient proof of safety. The agency subsequently suspended the order pending Juul's appeal. However, sources reveal that Juul's sales in the U.S. continued to decline, prompting the company to abandon their overseas plans.


Juul faces thousands of lawsuits accusing the company of selling its products to children. Some of these lawsuits are scheduled to go to trial next year. Disputes with the FDA have hindered Juul's ability to raise funds or obtain traditional bank loans to pay for legal settlements or court judgments.


Since last year, Juul has agreed to pay over $525 million in settlements to several states that have been investigating or taking legal action against the company. There are still pending cases, including lawsuits filed by nine other attorneys general. The company maintains that it has never targeted underage users.


According to a federal investigation released on Thursday, Juul did not make it to the list of the most popular e-cigarette brands used by high school students.


Statement:


This article is compiled based on third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The compilation of this article is only intended for industry-related communication and research.


Due to limitations in our translation capabilities, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government in regards to any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
Philip Morris International (PMI) showcased IQOS heated tobacco systems and nicotine pouch products at Technovation 2026 in Buenos Aires on October 7–8, presenting research on consumer attitudes, regulatory developments and illicit cigarette trade across Latin America. PMI Chief Global Growth Officer Stefano Volpetti said smoke-free products accounted for more than 7% of the Mexico City market. Argentina repealed its heated tobacco ban in May 2026 and introduced registration requirements for tobacco and nicotine products, while local media reported nicotine pouch sales in Mendoza. A PMI-commissioned survey found that only 8% of respondents across four Latin American countries were familiar with nicotine pouches. A separate KPMG study estimated illicit cigarette consumption at 77 billion sticks across 11 markets in Latin America and Canada in 2025.
PMI
Oct.13
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19